Ramon Staeger

9PUBLICATIONS
82CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Image processing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 26, 2025
Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints Targeted.

Lukas Kraehenbuehl, Nicola Winkelbeiner, Patrick Turko

|Sep 14, 2024
Distinct Variations in Gene Expression and Cell Composition across Lichen Planus Subtypes.

Cadri Knoch, Veronika Baghin, Patrick Turko

|Aug 29, 2024
A targetable type III immune response with increase of IL-17A expressing CD4+ T cells is associated with immunotherapy-induced toxicity in melanoma.

Florentia Dimitriou, Phil F Cheng, Annalisa Saltari

|Jun 25, 2024
COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma.

Mauro Esposito, Laura Yerly, Prachi Shukla

|Mar 13, 2024
Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland.

Ramon Staeger, Julia M Martínez-Gómez, Patrick Turko

|Oct 20, 2023
Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 Therapy.

Nina Zila, Ossia M Eichhoff, Irene Steiner

Pageof 2

Frequent Collaborators

6 joint publications

Mitchell P Levesque

6 joint publications

Reinhard Dummer

4 joint publications

Patrick Turko

3 joint publications

Phil F Cheng